Andrew Stern, MD PhD
@andrewmstern
Neurologist and Alzheimer disease basic scientist at the Ann Romney Center for Neurologic Diseases @BWHNeurology. Associate PD for Research @harvardneuromds
My lab is hiring a postdoc to work on new TDP-43 biomarkers! Please get in touch and/or retweet!
Another denial from @WellcarePlans and @EvolentHealth, this time an MRI for a patient to make sure they don’t have a brain tumor. Routed around the call system, representative grumbled something about AI, and then cut me off and transferred back to the main phone line.
Great news that the European Commission approved lecanemab today. @GovCanHealth next?
Hi @AbsAntibody, we made a custom antibody request and you keep sending us the wrong antibody. Also no one seems to answer the phone. Could you refund us or send the right antibody? IM me for PO number.
On behalf of all of my co-authors, I am sharing a collective response to the book "Doctored" by Charles Piller and in response to his NYT article promoting the book. @ApostolovaLiana @grinberg_t @holtzman4 @lab_lamb @clemere99 @MaluTansey @ers_net et al. Full author list shown.…
Looks like @WellcarePlans @EvolentHealth decided to deny my patient’s amyloid PET on the basis of Medicare NCDs for MRI and FDG PET. Fraud or incompetence?
Congratulations to all our @BrighamWomens award recipients who were honored at the 2024 Annual Meeting of the Medical Staff and Awards Ceremony! Here are just a few of them!
Dr. Mike Erkkinen presented What’s New in Alzheimer Disease Treatment last week as part of MADRC’s Talk With the Doc(tor) series. Dr. Erkkinen discussed the drugs recently approved by the FDA to treat Alzheimer’s disease. Watch here: bit.ly/TWTDSept202024 @BWHNeurology
I’m submitting my first R01. Do people prefer reviewing/submitting grants with two aims or three? Almost all R01s I’ve read have three, but @HarvardCatalyst GRASP recommends two. @M_B_Miller
The @MassGenBrigham Alzheimer Therapeutics Program (ATP), our standalone clinic for anti-amyloid (and hopefully other future disease-modifying) therapy has a new website! brighamandwomens.org/neurology/cogn…
Always great to see new amyloid cryoEM structures. However is Fig 6 here supported? Do we know that cored plaques have type I and diffuse plaques have type II? link.springer.com/article/10.100… @yyang_cella @SjorsScheres @MichelGoed
We're hiring a Research Assistant to join our collaborative team! Gain hands-on training in human stem cells and explore the genetic & molecular basis of neurodegenerative and neurodevelopmental diseases. Please share! If you’re interested send your cv to [email protected]
Congratulations to Michael McCormick, PA-C, MS on receiving a @BrighamWomens 2024 PA Rising Star Award.🧠
#NewFaculty Dr. Priya Srikanth will join the Divisions of @BWHNeuroICU and Neurorecovery at @MassGenBrigham on July 1. Welcome, Priya!